Advanced search
Publication Cover
International Reviews of Immunology Volume 21, 2002 - Issue 2-3
Submit an article Journal homepage
79
Views
49
CrossRef citations to date
0
Altmetric
Research Article

IMMUNOLOGY AND IMMUNOMODULATION OF CORNEAL TRANSPLANTATION

JERRY Y. NIEDERKORN Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
Pages 173-196 | Published online: 03 Aug 2009

  • H. Auchincloss, Jr., T. Mayer, R. Ghobrial, and H.J. Winn, T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. Immunol. Res., 8: 149-164, 1989.
  • H. Auchincloss, Jr., and H. Sultan, Antigen processing and presentation in transplantation. Curr. Opin. Immunol., 8: 681-687, 1996.
  • W. Ayliffe, Y. Alam, E.B. Bell, D.M. Leod, and I.V. Hutchinson, Prolongation of rat corneal graft survival by treatment with anti-CD4 monoclonal antibody. Br. J. Ophthalmol., 76: 602-606, 1992.
  • J. Banchereau and R.M. Steinman, Dendritic cells and the control of immunity. Nature, 392: 245-252, 1998.
  • C.F. Barkerand R.E. Billingham, The role of afferent lymphatics in the rejection of skin homografts. J. Exp. Med., 128: 197-221, 1968.
  • P.K. Basu, I. Miller, and H.L. Ormsby, Sex chromatin as a biologic cell marker in the study of the fate of corneal transplants. Amer. J. Ophthalmol., 49: 513-515, 1960.
  • S.L. Bigger, An inquiry into the possibility of transplanting the cornea with the view of relieving blindness (hitherto deemed incurable) caused by several diseases of that structure. Dublin J. Med. Sci., 11: 408-447, 1837.
  • F. Boisgerault, Y. Liu, N. Anosova, E. Ehrlich, M.R. Dana, and G. Benichou, Role of CD4+ and CDS+ T cells in allorecognition: Lessons from corneal transplantation. J. Immunol., 167: 1891-1899, 2001.
  • D. Callanan, J. Peeler, and J.Y. Neiderkorn, Characteristics of rejection of orthotopic corneal allografts in the rat. Transplantation, 45: 437-443, 1988.
  • D.G. Callanan, M.W. Luckenbach, B.J. Fischer, J.S. Peeler, and J.Y. Neiderkorn, Histopathology of rejected orthotopic corneal grafts in the rat. Invest. Ophthalmol. Vis. Sci., 30: 413-424, 1989.
  • R.I. Carr, J. Zhou, J.A. Rearsey, A.W. Stadnyk, and T.D. Lee, Prolongation of survival of primary renal allografts by feeding of donor spleen cells. Transplantation, 66: 976-982, 1998.
  • J.W. Chandler, R. Leder, H.E. Kaufman, and J.R. Caldwell, Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor. Invest. Ophthalmol., 13: 151-153, 1974.
  • A. Choudhury, V.A. Pakalnis, and W.E. Bowers, Function and cell surface phenotype of dendritic cells from rat cornea. Invest. Ophthalmol. Vis. Sci., 36: 2602-2613, 1995.
  • I. Claassen, N. Van Rooijen, and E. Clausen, A new method for removal of mononuclear phagocytes from heterogeneous cell populations in vitro, using the liposome-mediated macrophage 'suicide' technique. J. Immunol. Methods, 134: 153-161, 1990.
  • M.R. Dana, J. Yamada, and J.W. Streilein, Topical interleukin-1 receptor antagonist promotes corneal transplant survival. Transplantation, 63: 1501-1507, 1997.
  • L.J. Dekaris, J.J. Yamada, J.W. Streilein, and R.M. Dana, Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts. Curr. Eye. Res., 19: 456-459, 1999.
  • N. Ehlers, T. Olsen, and H.E. Johnsen, Corneal graft rejection probably mediated by antibodies. Acta. Ophthalmol. (Copenh), 59: 119-125, 1981.
  • M. Falcone and B.R. Bloom, AT helper cell 2 (Th2) immune response against non-self antigens modifies the cytokine profile of autoimmune T cells and protects against experimental allergic encephalomyelitis. J. Exp. Med., 185: 901-907, 1997.
  • E.H. Field, Q. Gao, N.X. Chen, and T.M. Rouse, Balancing the immune system for tolerance: A case for regulatory CD4 cells. Transplantation, 64: 1-7, 1997.
  • G.N. Foulks, J.Y. Niederkorn, and F. Sanfilippo, Corneal allograft rejection. Ocular Infection and Immunity. J.S. Pepose, G.N. Holland, K.R. Wilhelmus, eds. St. Louis: Mosby, 435-445, 1996.
  • B.M. Gebhardt, M. Hodkin, E.D. Varnell, and H.E. Kaufman, Protection of corneal allografts by CTLA4-Ig. Cornea, 18: 314-320, 1999.
  • B.M. Gebhardt, E.D. Varnell, and H.E. Kaufman, Prolonged survival of corneal allografts incubated in alloantibody fragments. Transplantation, 67: 594-599, 1999.
  • M. Goldman, A. Le Moine, M. Braun, V. Flamand, and D. Ambrance, A role for eosinophils in transplant rejection. Trends Immunol., 22: 247-251, 2001.
  • W.R. Goslings, A.P. Prodeus, J.W. Streilein, M.C. Carroll, M.J. Jager, and A.W. Taylor, A small molecular weight factor in aqueous humor acts on C1q to prevent antibody-dependent complement activation. Invest. Ophthalmol. Vis. Sci., 39: 989-995, 1998.
  • W.R. Goslings, J. Yamada, M.R. Dana, J.W. Streilein, E. Van Beelan, A.P. Prodeus, M.C. Carroll, and M.J. Jager, Corneal transplantation in antibody-deficient hosts. Invest. Ophthalmol. Vis. Sci., 40: 250-253, 1999.
  • T.S. Griffithand T.A. Ferguson, The role of FasL-induced apoptosis in immune privilege. Immunol. Today, 18: 240-244, 1997.
  • A.B. Hahn, G.N. Foulks, C. Enger, N. Fink, W.J. Stark, K.A. Hopkins, and F. Sanfilippo, The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. The Collaborative Corneal Transplantation Studies Research Group. Transplantation, 59: 21-27, 1995.
  • B.M. Hall, Cells mediating allograft rejection. Transplantation, 51: 1141-1151, 1991.
  • C. Hanna, Fate of cells in the transplant. Surv. Ophthalmol., 11: 405-414, 1966.
  • Y. He, J. Mellon, R. Apte, and J.Y. Niederkorn, Effect of LFA-1 and ICAM-1 antibody treatment on murine corneal allograft survival. Invest. Ophthalmol. Vis. Sci., 35: 3218-3225, 1994.
  • Y.G. He, J. Mellon, J.Y. Niederkorn, The effect of oral immunization on corneal allograft survival. Transplantation, 61: 920-926, 1996.
  • Y.G. Heand J.Y. Niederkorn, Depletion of donor-derived Langerhans cells promotes corneal allograft survival. Cornea, 15: 82-89, 1996.
  • Y.G. He, J. Ross, and J.Y. Niederkorn, Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody. Invest. Ophthalmol. Vis. Sci., 32: 2723-2728, 1991.
  • S. Hegde and J.Y. Niederkorn, The role of cytotoxic T lymphocytes in corneal allograft rejection. Invest. Ophthalmol. Vis. Sci., 41: 3341-3347, 2000.
  • F. Hoffmann, E.P. Zhang, T. Pohl, U. Kunzendorf, J. Wachtlin, and S. Bulfane-Paus, Inhibition of corneal allograft reaction by CTLA4-Ig. Graefes Arch. Clin. Exp. Ophthalmol., 235: 535-540, 1997.
  • N. Ishido, J. Matsuoka, T. Nakagawa, and N. Tanakin, Induction of donor-specific hyporesponsiveness and prolongation of cardiac allograft survival by jejunal administration of donor splenocytes. Transplantation, 68: 1377-1382, 1999.
  • N. Ishii, I. Aoki, T. Ishii, N. Mizuki, K. Okuda, and H. Nakajima, Suppressor T cells in mice made unresponsive to skin allografts. J. Invest. Dermatol., 91: 333-335, 1988.
  • M.J. Jager, A. Vos, S. Pasmans, R. Hoekzema, L. Broersma, and R. Vander Gaag, Circulating cornea-specific antibodies in corneal disease and cornea transplantation. Graefes Arch. Clin. Exp. Ophthalmol., 232: 82-86, 1994.
  • A.A. Khodadoustand A.M. Silverstein, Induction of corneal graft rejection by passive cell transfer. Invest. Ophthalmol., 15: 89-95, 1976.
  • S. Klebe, P.J. Sykes, D.J. Coster, R. Krishnan, and K.A. Williams, Prolongation of sheep corneal allograft survival by ex vivo transfer of the gene encoding interleukin-10. Transplantation, 71: 1214-1220, 2001.
  • B.R. Ksander, Y. Sano, and J.W. Streilein, Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes. Transpl. Immunol., 4: 49-52, 1996.
  • D.F. Larkin, R.A. Alexander, and I.A. Cree, Infiltrating inflammatory cell phenotypes and apoptosis in rejected human corneal allografts. Eye, 11: 68-74, 1997.
  • J.H. Lass, E.I. Walter, I.E. Buris, H.E. Grosniklaus, M.I. Roat, D.L. Selnick, L. Needham, M. Singer, and M.E. Medof, Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Invest. Ophthalmol. Vis. Sci., 31: 1136-1148, 1990.
  • F.Y. Liew, Regulation of delayed-type hypersensitivity. VI. Antigen-specific suppressor T cells and suppressor factor for delayed-type hypersensitivity to histocompatibility antigens. Transplantation, 33: 69-76, 1982.
  • Z. Liu, Y.K. Sun, Y.P. Xi, A. Maffei, E. Reed, P. Harris, and N. Suciu-Foca, Contribution of direct and indirect recognition pathways to T cell alloreactivity. J. Exp. Med., 177: 1643-1650, 1993.
  • B. Lowin, M. Hahne, C. Mattmann, and J. Tschopp, Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature, 370: 650-652, 1994.
  • D. Ma, J. Mellon, and J.Y. Niederkorn, Oral immunisation as a strategy for enhancing corneal allograft survival. Br. J. Ophthalmol., 81: 778-784, 1997.
  • D. Ma, J. Mellon, and J.Y. Niederkorn, Conditions affecting enhanced corneal allograft survival by oral immunization. Invest. Ophthalmol. Vis. Sci., 39: 1835-1846, 1998.
  • A.Y. Matoba, J.S. Peeler, J.Y. Niederkorn, T cell subsets in the immune rejection of murine heterotopic corneal allografts. Invest. Ophthalmol. Vis. Sci., 27: 1244-1254, 1986.
  • A. Maumenee, The influence of donor-recipient sensitization on corneal grafts. Am. J. Ophthalmol., 34: 142-152, 1951.
  • T.R. Mosmannand S. Sad, The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today, 17: 138-146, 1996.
  • J.Y. Niederkorn, Animal models of corneal transplantation. Immunology of Corneal Transplantation. Zierhut M., U. Pleyer, H-J. Thiel. Buren, eds. The Netherlands: Aeolus Press, 177-189, 1994.
  • J.Y. Niederkorn, Anterior chamber-associated immune deviation. Chem. Immunol., 73: 59-71, 1999a.
  • J.Y. Niederkorn, The immune privilege of corneal allografts. Transplantation, 67: 1503-1508, 1999b.
  • J.Y. Niederkorn, The immunology of corneal transplantation. Dev. Ophthalmol., 30: 129-140, 1999c.
  • J.Y. Niederkornand J. Mellon, Anterior chamber-associated immune deviation promotes corneal allograft survival. Invest. Ophthalmol. Vis. Sci., 37: 2700-2707, 1996.
  • J.Y. Niederkorn, J.S. Peeler, and J. Mellon, Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol., 2: 83-90, 1989.
  • J.S. Peelerand J.Y. Niederkorn, Antigen presentation by Langerhans cells in vivo: Donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens. J. Immunol., 136: 4362-4371, 1986.
  • J.S. Pepose, M.S. Nestor, K.M. Gardner, R.Y. Foos, and T.H. Petit, Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch. Clin. Exp. Ophthalmol., 222: 128-133, 1985.
  • U. Pleyer, J.K. Milani, A. Dukes, J. Chou, S. Lutz, D. Ruckert, H.J. Thiel, and B.J. Mondino, Effect of topically applied anti-CD4 monoclonal antibodies on or- thotopic corneal allografts in a rat model. Invest. Ophthalmol. Vis. Sci., 36: 52-61, 1995.
  • J. Ross, D. Callanan, H. Kunz, and J. Niederkorn, Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression. Transplantation, 51: 532-536, 1991.
  • J. Ross, Y.G. He, and J.Y. Niederkorn, Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response. Curr. Eye Res., 10: 889-892, 1991a.
  • J. Ross, Y.G. He, M. Pidherney, J. Mellon, J.Y. Niederkorn, The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts. Transplantation, 52: 857-861, 1991b.
  • M.H. Sayegh, Z.J. Zhang, W.W. Hancock, C.A. Kwok, C.B. Carpenter, and H.L. Weiner, Down-regulation of the immune response to histocompatibility antigens and prevention of sensitization by skin allografts by orally administered allo- antigen. Transplantation, 53: 163-166, 1992.
  • S.C. Sheand E.J. Moticka, Ability of intracamerally inoculated B- and T-cell enriched allogeneic lymphocytes to enhance corneal allograft survival. Int. Ophthalmol., 17: 1-7, 1993.
  • S.C. She, L.P. Steahly, and E.J. Motika, Intracameral injection of allogeneic lymphocytes enhances corneal graft survival. Invest. Ophthalmol. Vis. Sci., 31: 1950-1956, 1990.
  • W.E. Smiddy, W.J. Stark, E. Young, P.E. Klein, W.D. Bias, and R.E. Maumenec, Clinical and immunological results of corneal allograft rejection. Ophthalmic Surg., 17: 644-649, 1986.
  • G. Smolin and R.A. Hyndiuk, Lymphatic drainage from vascularized rabbit cornea. Am. J. Ophthalmol., 72: 147-151, 1971.
  • J.H. Sohn, H.J. Kaplan, H.J. Suk, P.S. Bora, and N.S. Bora, Complement regulatory activity of normal human intraocular fluid is mediated by MCP, DAF, and CD59. Invest. Ophthalmol. Vis. Sci., 41: 4195-4202, 2000.
  • Y. Sonoda and J.W. Streilein, Orthotopic corneal transplantation in mice -- evidence that the immunogenetic rules of rejection do not apply. Transplantation, 54: 694-704, 1992.
  • Y. Sonoda and J.W. Streilein, Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts. J. Immunol., 150: 1727-1734, 1993.
  • R.M. Steinman, Dendritic cells and the control of immunity: Enhancing the efficiency of antigen presentation. Mt. Sinai. J. Med., 68: 106-166, 2001.
  • J.W. Streilein, Immune privilege as the result of local tissue barriers and im- munosuppressive microenvironments. Curr. Opin. Immunol., 5: 428-432, 1993.
  • J.W. Streilein, J. McCulley, and J.Y. Niederkorn, Heterotopic corneal grafting in mice: A new approach to the study of corneal alloimmunity. Invest. Ophthalmol. Vis. Sci., 23: 489-500, 1982.
  • P.M. Stuart, T.S. Griffith, N. Usui, J. Pepose, X. Yu, and T.A. Ferguson, CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival. J. Clin. Invest., 99: 396-402, 1997.
  • R.D. Stulting, G.O. Waring, 3rd, W.Z. Bridges, and H.D. Cavanagh, Effect of donor epithelium on corneal transplant survival. Ophthalmology, 95: 803-812, 1988.
  • J. Sugar, The Collaborative Corneal Transplantation Studies. Arch. Ophthalmol., 110: 1517-1518, 1992.
  • J.B. Sun, J. Holmgren, and C. Czerkinsky, Cholera toxin B subunit: An efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc. Natl. Acad. Sci., USA 91: 10795-10799, 1994.
  • P.A. Treseler, G.N. Foulks, and F. Sanfilippo, The relative immunogenicity of corneal epithelium, stroma, and endothelium. The role of major histocompatibility complex antigens. Transplantation, 41: 229-234, 1986.
  • G. Van der Veen, L. Broersma, C.D. Dijkstra, N. Van Rooijen, G. Van Rij, and R. Vander Gaag, Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest. Ophthalmol. Vis. Sci., 35: 3505-3515, 1994.
  • C.F. Whitsettand R.D. Stulting, The distribution of HLA antigens on human corneal tissue. Invest. Ophthalmol. Vis. Sci., 25: 519-524, 1984.
  • K.A. Williamsand D.J. Coster, Penetrating corneal transplantation in the inbred rat: A new model. Invest. Ophthalmol. Vis. Sci., 26: 23-30, 1985.
  • N.S. Williamsand V.H. Engelhard, Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells. J. Immunol., 159: 2091-2099, 1997.
  • S.E. Wilson, Q. Li, J. Weng, P.A. Barry-Lane, J.V Jester, Q. Liang, and R.J. Wordinger, The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Invest. Ophthalmol. Vis. Sci., 37: 1582-1592, 1996.
  • J. Yamada, I. Kurimoto, and J.W Streilein, Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Invest. Ophthalmol. Vis. Sci., 40: 2614-2621, 1999.
  • J. Yamada, M. Yoshida, A.W Taylor, and J.W. Streilein, Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in 'high risk' eyes. J. Immunol., 162: 5247-5255, 1999.
  • S. Yamagami and M.R. Dana, The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest. Ophthalmol. Vis. Sci., 42: 1293-1298, 2001.
  • S. Yamagami, H. Kawashima, et al., Role of Fas-Fas ligand interactions in the immunorejection of allogeneic mouse corneal transplants. Transplantation, 64: 1107-1111, 1997.
  • S. Yamagami, T. Tsuru, et al., Suppression of allograft rejection with antialphabeta T cell receptor antibody in rat corneal transplantation. Transplantation, 67: 600-604, 1999.
  • Y.F. Yao, Y. Inoue, et al., Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice. Invest. Ophthalmol. Vis. Sci., 38: 292-300, 1997.
  • J. Zhou, R.I. Carr, et al., Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J. Immunol., 167: 107-113, 2001.
  • E. Zirm, Eine erfolgreiche totale Keratoplastik. Albrecht von Graefes Arch. Ophthalmol., 64: 580-593, 1906.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.